{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:44Z","timestamp":1786988144095,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejps.2005.11.005","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T08:30:20Z","timestamp":1135240220000},"page":"354-362","source":"Crossref","is-referenced-by-count":81,"title":["Development and evaluation of an in vitro method for prediction of human drug absorption"],"prefix":"10.1016","volume":"27","author":[{"given":"Giovanna","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maestrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Cirri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Zerrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2005.11.005_bib1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1023\/B:PHAM.0000008043.71001.43","article-title":"Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis","volume":"20","author":"Alsenz","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical prediction of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejps.2005.11.005_bib3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/PL00012496","article-title":"Physicochemical profiling in drug research: a brief state of the art of the experimental techniques","volume":"59","author":"Avdeef","year":"2003","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1056-8719(00)00113-1","article-title":"Current methodologies used for evaluation of intestinal permeability and absorption","volume":"44","author":"Balimane","year":"2000","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.ejps.2005.11.005_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(95)00146-8","article-title":"The potential of mucoadhesive polymer in enhancing intestinal peptide drug absorption. III. Effect of chitosan\u2013glutamate and carbomer on epithelial tight junction in vitro","volume":"39","author":"Borchard","year":"1996","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2005.11.005_bib6","first-page":"297","article-title":"Biowaiver extension potential to BCS class III high solubility\u2013low permeability drugs: bridging evidence for metformin immediate-release tablet","volume":"22","author":"Cheng","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1007552927404","article-title":"Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans","volume":"17","author":"Chiou","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib8","doi-asserted-by":"crossref","unstructured":"Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., Mura, P., 2005. Development and evaluation of an in vitro method for high-throughput prediction of human drug absorption. I. Assessment of the artificial membrane composition. Eur. J. Pharm. Sci., doi:10.1016\/j.ejps.2005.11.004.","DOI":"10.1016\/j.ejps.2005.11.004"},{"key":"10.1016\/j.ejps.2005.11.005_bib9","series-title":"Guidance for Industry: Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System","author":"FDA","year":"2000"},{"key":"10.1016\/j.ejps.2005.11.005_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1018868123367","article-title":"Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat Jejunum","volume":"16","author":"Flanagan","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jps.10099","article-title":"Contributions of saturable active secretion, passive transcellular and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells","volume":"91","author":"Flanagan","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(02)00047-7","article-title":"Synthesis of analogs of l-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells","volume":"16","author":"Friedrichsen","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/1568026033452014","article-title":"Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability","volume":"3","author":"Gombar","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2005.11.005_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ddtec.2004.09.004","article-title":"Predicting the intestinal absorption potential of hits and leads","volume":"1","author":"H\u00e4m\u00e4l\u00e4inen","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2005.11.005_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1023\/A:1015848205447","article-title":"Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus","volume":"8","author":"Hidalgo","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1023\/A:1015906409585","article-title":"Mechanism of l-alpha-methyl-dopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)","volume":"12","author":"Hu","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2004.07.009","article-title":"Permeability through DOPC\/dodecane membranes: measurement and LFER modelling","volume":"23","author":"Huque","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib18","first-page":"315","article-title":"Permeation prediction of M100240 using the parallel artificial membrane permeability assay","volume":"6","author":"Hwang","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high-throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2005.11.005_bib21","series-title":"Pharmacokinetic Optimization in Drug Research","first-page":"447","article-title":"High-throughput artificial membrane permeability studies in early lead discovery and development","author":"Kansy","year":"2001"},{"key":"10.1016\/j.ejps.2005.11.005_bib22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/jps.1134","article-title":"High-throughput physicochemical profiling for drug discovery","volume":"90","author":"Kerns","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jps.20075","article-title":"Combined application of parallel artificial membrane permeability assays in drug discovery","volume":"93","author":"Kerns","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(95)04204-0","article-title":"Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo","volume":"127","author":"Lennernas","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpharm.2003.11.024","article-title":"Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells","volume":"271","author":"Maestrelli","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib26","first-page":"598","article-title":"Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa","volume":"9","author":"Miret","year":"2004","journal-title":"J. Biomed. Scr."},{"key":"10.1016\/j.ejps.2005.11.005_bib27","series-title":"Clarke's Analysis of Drugs and Poisons","author":"Moffat","year":"2003"},{"key":"10.1016\/j.ejps.2005.11.005_bib28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jps.10409","article-title":"Experimental demonstration of the unstirred water layer effect on drug transport in caco-2 cells","volume":"92","author":"Naruhashi","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(95)04259-8","article-title":"Transfer of metformin across monolayers of human intestinal Caco-2 cells and across rat intestine","volume":"128","author":"Nicklin","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/DDC-120028713","article-title":"Biopharmaceutics classification by high-throughput solubility assay and PAMPA","volume":"30","author":"Obata","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","article-title":"Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the caco-2 cell culture model","volume":"14","author":"Pade","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/js980111k","article-title":"Link between drug absorption solubility and permeation measurements in Caco-2 cells","volume":"87","author":"Pade","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/B:PHAM.0000026423.48583.e2","article-title":"Correction of permeability with pore radium of tight junctions in caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans","volume":"21","author":"Saitoh","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(01)00845-6","article-title":"Optimized conditions of bio-mimetic artificial membrane permeation assay","volume":"228","author":"Sugano","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2005.11.005_bib35","series-title":"Drug Bioavailability, Estimation of Solubility, Permeability, Absorption and Bioavailability","first-page":"90","article-title":"Cell cultures in drug discovery and industrial perspective","author":"Ungell","year":"2003"},{"key":"10.1016\/j.ejps.2005.11.005_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ddtec.2004.11.003","article-title":"Caco-2 replace or refine","volume":"1","author":"Ungell","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2005.11.005_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0022-3565(24)37707-9","article-title":"Transport of l-Valine-Aciclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2","volume":"286","author":"Vrueh","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.ejps.2005.11.005_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.11.005_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/B:PHAM.0000016242.48642.71","article-title":"The \u201chigh solubility\u201d definition of the current FDA guidance on biopharmaceutical classification system may be too strict for acidic drugs","volume":"21","author":"Yazdanian","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2005.11.005_bib40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1359-6446(03)02873-3","article-title":"In vitro trans-monolayers permeability calculations: often forgotten assumptions","volume":"8","author":"Youdim","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2005.11.005_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0223-5234(02)01360-0","article-title":"A comparative study of artificial membrane permeability assay for high-throughput profiling of drug absorption potential","volume":"37","author":"Zhu","year":"2002","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098705003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098705003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:37:01Z","timestamp":1736170621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098705003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0928098705003350"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2005.11.005","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}